Early results from the TUSCANY trial highlight promising remission rates and safety for a new triplet therapy in treating ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, ...

Updated data from the BEXMAB study reveals a significant increase in complete remission rates for patients with high-risk ...

Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment—immunotherapy—may help change the environment where cancer ...

“The treatment for acute myeloid leukemia is still pretty limited. And the only curative treatment right now is bone marrow transplantation, but as also its limit.

The FDA has accepted the sNDA for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed AML who are ineligible for intensive induction chemotherapy.

Daunorubicin dose intensification has benefits in select patients with acute myeloid leukemia.

Loren Ruch, who co-hosted the 2021 series HGTV House Party and served as HGTV's head of content, has died at age 55. Variety reports that Ruch died Thursday, June 12, of acute myeloid leukemia.

A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia (AML) showed high rates of complete remission in an early-phase ...

New results for Johnson & Johnson's bleximenib demonstrate promising antileukemic activity in combination with venetoclax and azacitidine for acute myeloid leukemia ...

An artificial intelligence (AI)-driven machine learning model was refined and validated internationally to accurately classify acute leukemia subtypes from routine laboratory data, according to ...

Kura Oncology’s ziftomenib addresses a specific genetic mutation present in about 30% of cases of acute myeloid leukemia. Data from the drug’s pivotal Phase 2 test were presented during the ...